CORNERCAP INVESTMENT COUNSEL INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
CORNERCAP INVESTMENT COUNSEL INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$1,321,238
+14.9%
35,233
-14.2%
0.23%
+17.1%
Q4 2022$1,150,109
-0.3%
41,0460.0%0.20%
-8.7%
Q3 2022$1,153,000
+10.1%
41,046
+36.3%
0.22%
+19.8%
Q2 2022$1,047,000
-37.9%
30,107
-35.9%
0.18%
-3.7%
Q1 2022$1,687,000
+22.8%
46,995
-20.3%
0.19%
-5.0%
Q4 2021$1,374,000
+25.4%
58,975
+2.3%
0.20%
+59.2%
Q3 2021$1,096,000
-16.3%
57,649
-11.2%
0.12%
-13.8%
Q2 2021$1,309,000
+30.5%
64,924
+18.6%
0.14%
+29.5%
Q1 2021$1,003,000
+157.2%
54,751
+163.4%
0.11%
+103.6%
Q3 2020$390,00020,7900.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders